Retatrutide Comparisons
How retatrutide stacks up against tirzepatide, semaglutide, and the leading brand-name GLP-1 medicines: mechanism, trials, and approval status, side by side.
Retatrutide vs Tirzepatide: How the Two Compare
Retatrutide is an investigational triple agonist; tirzepatide (Mounjaro/Zepbound) is an approved dual agonist. Compare mechanism, trial results, dosing, and approval status.
Retatrutide vs Semaglutide: What's the Difference?
Retatrutide is an investigational triple agonist; semaglutide (Ozempic/Wegovy) is an approved GLP-1 drug. Compare mechanism, trial results, dosing, and approval status.
Retatrutide vs Mounjaro: How They Compare
Mounjaro is approved tirzepatide for type 2 diabetes; retatrutide is an investigational triple agonist. Compare mechanism, approval status, trial results, and dosing.
Retatrutide vs Wegovy: How They Compare
Wegovy is approved semaglutide for weight management; retatrutide is an investigational triple agonist. Compare mechanism, approval status, trial results, and dosing.
Retatrutide vs Ozempic: How They Compare
Ozempic is approved semaglutide for type 2 diabetes; retatrutide is an investigational triple agonist. Compare mechanism, approval status, trial results, and dosing.
Tirzepatide vs Semaglutide: A Head-to-Head Comparison
Compare tirzepatide (Mounjaro/Zepbound) and semaglutide (Ozempic/Wegovy): mechanism, SURMOUNT-5 head-to-head weight-loss results, dosing, side effects, and brands.
Retatrutide vs Tirzepatide
The most-searched comparison: how Eli Lilly's investigational triple agonist stacks up against tirzepatide (Mounjaro and Zepbound).
On a weekly retatrutide routine?
RetaPal keeps your weekly dose log, injection countdown, and hunger check-ins in one private app. It never recommends or calculates doses.
Get Started